The Pediatric BMT Program provides transplantation of hematopoietic (or blood) stem cells derived from the bone marrow as a treatment option for a variety of acquired and congenital disorders of children and young adults, including:
- Acute and chronic leukemia
- Hodgkin and non-Hodgkin lymphomas
- Sarcomas
- Brain tumors
- Bone marrow failure syndromes
- Inherited immune deficiency syndrome
- Metabolic disorders